Grimstad T, Carlsen A, Kvaløy JT, Bolstad N, Warren DJ, Aabakken L, Lundin KEA, Karlsen L, Steinsbø Ø, Omdal R(2025) Fatigue in Inflammatory Bowel Disease: No Effect of Serum Concentrations of Infliximab, Adalimumab or Anti-Drug Antibodies During Maintenance Therapy Scand J Immunol, 101(5), e70029 DOI 10.1111/sji.70029, PubMed 40289444
Hansen SH, Maseng MG, Grännö O, Vestergaard MV, Bang C, Olsen BC, Lund C, Olbjørn C, Løvlund EE, Vikskjold FB, Huppertz-Hauss G, Perminow G, Yassin H, Valeur J, Aass Holten KI, Henriksen M, Bengtson MB, Ricanek P, Opheim R, Boyar R, Torp R, Frigstad SO, Aabrekk TB, Detlie TE, Kristensen VAet al.(2025) Fecal Microbiome Reflects Disease State and Prognosis in Inflammatory Bowel Disease in an Adult Population-Based Inception Cohort Inflamm Bowel Dis(in press) DOI 10.1093/ibd/izaf060, PubMed 40285477
Dahl TB, Aftab F, Prebensen C, Berdal JE, Ueland T, Barratt-Due A, Riise AMD, Ueland PM, Hov JR, Trøseid M, Aukrust P, Gregersen I, Myhre PL, Omland T, Halvorsen B(2025) Imidazole propionate is increased in severe COVID-19 and correlates with cardiac involvement J Infect, 106494(in press) DOI 10.1016/j.jinf.2025.106494, PubMed 40280497
Lorentsen JLL, Brunborg C, Aasebø AT, Valeur J, Haavardsholm EA, Molberg Ø, Palm Ø, Lerang K(2025) Incidence and prevalence of Behçet's disease in Oslo Norway: a two-decade population-based analysis Rheumatology (Oxford)(in press) DOI 10.1093/rheumatology/keaf224, PubMed 40279276
